TD Private Client Wealth’s Avanos Medical AVNS Stock Holding History

TD Private Client Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13	Closed	-$323	–	1780
2026 Q2	$323	Hold	13	–	–	﹤0.01%	1602
2026 Q1	$182	Hold	13	–	–	﹤0.01%	1582
2025 Q4	$146	Buy	+13	New	+$149	﹤0.01%	1575

Other funds holding AVNS

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

TD Private Client Wealth's AVNS Position: Q3 2026 in Review

TD Private Client Wealth sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 13 shares — an estimated $323 sold.

TD Private Client Wealth first reported a position in AVNS in Q4 2025 and held it in 3 quarters. The position peaked at $323 in Q2 2026. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

TD Private Client Wealth reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
TD Private Client Wealth sold 13 Avanos Medical shares in Q3 2026, an estimated $323.
TD Private Client Wealth first reported a position in Avanos Medical in Q4 2025 and held it in 3 quarters.
TD Private Client Wealth's Avanos Medical position peaked at $323 in Q2 2026.
2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.